EDAP TMS SA FOCL
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 1997-08-01
EDAP TMS SA statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 42.5% | 41.4% | 40.4% | 43.9% | 41.8% |
| Operating margin | -35.0% | -32.0% | -32.8% | -7.7% | -3.7% |
| Net margin | -41.5% | -29.7% | -35.0% | -5.3% | 1.6% |
| Return on assets | -37.0% | -23.0% | -23.1% | -2.9% | 0.9% |
| Return on equity | -150.7% | -48.5% | -33.7% | -4.1% | 1.4% |
| Debt / equity | 0.93× | 0.11× | 0.06× | 0.07× | 0.12× |
| Current ratio | 1.54 | 1.85 | 2.84 | 4.17 | 3.75 |
| Revenue growth | 1.6% | 14.8% | 9.6% | 25.1% | 5.8% |
Source: SEC EDGAR filings · CIK 0001041934 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.